Differences in metabolic and cardiovascular effects of pioglitazone vs. insulin glargine in the treatment of secondary drug failure in type 2 diabetes.
Phase of Trial: Phase IV
Latest Information Update: 24 Sep 2011
At a glance
- Drugs Insulin glargine (Primary) ; Pioglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 10 Mar 2008 New trial record.